Alarming eosinophils to combat tumors

Ariel Munitz, Simon Patrick Hogan*

*Corresponding author for this work

Research output: Contribution to journalComment/debate


Combined immunotherapy using checkpoint blockade (anti-CTLA4 and anti-PD-1) and the DPP4 inhibitor sitagliptin reveals the existence of a T cell– and eosinophil-targeted immunotherapy approach for solid tumors.

Original languageEnglish
Pages (from-to)250-252
Number of pages3
JournalNature Immunology
Issue number3
StatePublished - 1 Mar 2019


Dive into the research topics of 'Alarming eosinophils to combat tumors'. Together they form a unique fingerprint.

Cite this